Biomedical subjects

H Ibrahim

Publications and source records attributed to H Ibrahim.

14 recordsLinked to original sources

PubMed1992

Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass.

Cardiopulmonary bypass during open-heart surgery is sometimes associated with excessive perioperative bleeding. Following a non-randomized study suggesting that desmopressin acetate (desmopressin) reduced blood product requirements in these patients, we conducted a double-blind, placebo-controlled randomized trial of desmopressin (0.3 micrograms/kg, i. v.) in 92 patients with overt bleeding and a prolonged bleeding time. Mean blood loss during the first 24 h post-treatment was similar in the desmopressin and placebo groups (582 vs 465 ml, respectively; p = 0.15). Red-cell (p = 0.76), fresh frozen plasma (r = 0.66) and platelet unit (p = 0.74) requirements were also similar. The haemostatic effect of desmopressin has been attributed to the release of von Willebrand factor (vWF) and a reduced bleeding time. In our study, vWF and factor VIII:C levels increased while the bleeding time decreased significantly at 90 min and 24 h in both groups and, although vWF and factor VIII:C levels were slightly higher in desmopressin-treated patients at 90 min, the difference was not significant. Thrombin-antithrombin III complex, fibrinogen degradation product and tissue plasminogen activator levels, reflecting activation of the coagulation and fibrinolytic systems, respectively, decreased uniformly in both groups. We conclude that desmopressin is not useful in reducing blood loss or blood product requirements in patients with excessive immediate postoperative bleeding.

Adolescent↗

PubMed1991

A thyroid testing algorithm: results of a pilot study.

We conducted a pilot study to evaluate an algorithm for thyroid function testing consisting of initial serum thyrotropin values, measured by a sensitive immunoradiometric assay (TSH-IRMA), followed by a computer-directed decision to order further studies. We divided 216 outpatients according to their serum TSH-IRMA values as follows: suppressed (less than 0.1 mU/L, group I); low (0.1 to 0.4 mU/L, group II); normal (0.5 to 5.0 mU/L, group III); and high (greater than 5.0 mU/L, group IV). Thyroxine (T4), resin uptake (RU), and free thyroxine index (FTI) tests on groups I, II, and IV revealed that T4 and RU were normal for most patients in all groups and FTI was normal in 80% of group I, 93.4% of group II, and 93.3% of group IV. All patients in group I were designated hyperthyroid from either an exogenous or endogenous source. All patients in group II were clinically euthyroid except one; 50% were taking either L-thyroxine or propylthiouracil and 50% had no identifiable thyroid disease. Patients in group IV were hypothyroid. Overall, TSH was more effective in detecting both hypothyroidism and hyperthyroidism than either serum T4, RU ratio, or both combined in FTI since results of these measures fell in the normal range for most patients in all groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Algorithms↗

PubMed1989

Detection of sleep associated dysfunctional pharyngeal obstruction in infants.

Six infants were referred with symptoms and clinical signs suggesting airway obstruction during sleep. In each case, overnight recordings of arterial oxygen saturation, respiratory movements and end tidal expired carbon dioxide (ETCO2) showed the presence of abnormal episodes of hypoxaemia related to partial or complete airway obstruction and associated with a specific pattern of the inspiratory movement waveforms. These events and patterns were not found on recordings from 20 age-matched healthy infants and young children. ETCO2 levels were also abnormally elevated in all six patients when asleep. Fiber-optic upper airway endoscopy excluded structural abnormalities, including significant tonsillar or adenoidal enlargement, but showed an intermittent dysfunctional inspiratory obstruction in the pharynx. Continuous positive airways pressure and tracheostomy were effective in treating this obstruction.

Airway Obstruction↗

PubMed1989

[Block of the superior laryngeal nerve for ORL endoscopy. Description of a simplified technique].

The usual anterior and lateral routes used for superior laryngeal (SL) nerve blocks are not often used because too difficult to carry out. A simpler and easier technique is described, which blocks the SL nerve at the level of the greater cornu of the hyoid bone. Because the nerve is not located accurately with this technique, a larger volume of local anaesthetic is required. This technique was tested in 31 patients scheduled for endoscopies with rigid tubes. The mean duration of endoscopy was 30 +/- 10 min. The use of 8 ml 1% lidocaine for the block 30 min surgical anaesthesia. In 2 patients, the SL nerve block alone was sufficient. In 26 others a complement with a benzodiazepine (flunitrazepam, n = 9, mean dose 0.8 mg; midazolam, n = 17, mean dose 5 mg) was required. In 4 of these patients, attempts of oesophagoscopy gave rise to hypertension and tachycardia. General anaesthesia with propofol and tracheal intubation were therefore used. In the last 3 patients, intercricothyroid jet ventilation was used, requiring general anaesthesia (propofol and succinylcholine). The SL nerve block was satisfactory in 24 patients with total vocal cord paralysis and no haemodynamic reaction to painful stimuli in the blocked area. No complication was observed. It is concluded that this technique is useful and easier to carry out than the usual ones.

Anesthesia, General↗

PubMed1989

A bioequivalence study of two dipyridamole products.

Bioequivalence of Antiplate 75 mg was assessed versus Persantine 75 mg in a two-way crossover study. At the 5% confidence level, no significant difference was found between the area under the plasma concentration-time curves of the two products. The Cmax were comparable for both products. Quality control data including assay, content uniformity, disintegration and dissolution indicated that both products passed the pharmacopoeial requirements, USP XXI and BP 1980, Addendum 1983. It is concluded that Antiplate-75 is bioequivalent to Persantine.

Adult↗

PubMed1988